ArticleTropical animal health and production2024
Effect of Melia azedarach seed mediated nano-ZnO on growth performance, protein utilisation efficiency, haematology and nutritional status in pigs.
Article in Tropical animal health and production, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Biological applications and future perspectives of bioactive compounds as pig feed additives.Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2026Review
- Effects of zinc supplementation forms (ZnO, Zn-Lysine, Nano-ZnO) on growth performance and metabolic health in pre-weaned Holstein calves.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current study was conducted to investigate the effect of Melia azedarach seed-mediated ZnO nanoparticles on growth performance, protein utilisation efficiency, haematology and nutritional status in pigs. A total of 48 pigs were allocated to the following six treatments replicated 8 times: Negative Control (NC, No antibiotic), Treatment 2: Positive control (PC) given a conventional antibiotic (Oxytetracycline, 40 mg/kg feed); Treatment 3: Nano-ZnO 300 mg/L (N300ZnO), Treatment 4: Group given 150 mg/L Melia azedarach seed mediated nano-ZnO (N150MA), Treatment 5: Group given 300 mg/L Melia azedarach seed mediated nano-ZnO (N300MA), Treatment 6: Group given 450 mg/L Melia azedarach seed mediated nano-ZnO (N450MA). The experiment was conducted over 7 weeks. Melia azedarach seed-mediated ZnO nanoparticles had no significant effect on growth performance apart from average daily feed intake (ADFI) with treatment 3 having the highest value. It significantly affected protein consumption and growth efficiency but not protein efficiency ratio and specific growth rate. Melia azedarach seed-mediated ZnO nanoparticles had no significant impact on nutritional parameters, serum minerals apart from phosphorus which can negatively affect renal functioning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.